Esophageal
Protocol: RTOG 0436
Contact: CPLORD@stvincent.org
Title: A Phase III Trial Evaluating the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation for Patients with Esophageal Cancer Who Are Treated Without Surgery
Summary: The purpose of this study is to compare the effects of radiation therapy and chemotherapy (paclitaxel and cisplatin) with or without the addition of cetuximab to learn which treatment is more effective in the treatment of esophageal cancer.
–
Protocol: Moffitt
Title: Total Cancer Care™: A Partnership with High Risk and/or Diagnosed Cancer Patients for Life – 14690
Summary: This study is for patients undergoing surgery at the St.Vincent Indianapolis Hospital. The patient grants permission for St.Vincent Indianapolis Hospital to have access to the tissue removed, and they donate it to the Moffitt Cancer Center for use in research. This research will pursue improving cancer treatments and patients outcomes of cancer treatments, both current and future.